Pfizer has teamed up with Summit Therapeutics to assess whether one of the industry’s hottest cancer candidates works well ...
Patrizia Cavazzoni, the former director of the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research, ...
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE) and MercadoLibre, Inc. (MELI), as well as a micro-cap stock ...
Pfizer’s revenue in 2024 reached $63.6 ... We sell different types of products and services to both investment professionals and individual investors. These products and services are usually ...
Pfizer shares, which had risen Tuesday morning ... FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
In this article, we are going to take a look at where Pfizer Inc. (NYSE ... meaning demand for medical products and services remains steady, even during economic downturns. According to a report ...
Although Pfizer (NYSE:PFE) reiterated 2025 financial guidance issued in December, the midpoints of the ranges for revenue and EPS are below consensus figures. The pharmaceutical giant is ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the ... as the next head of the US Department of Health and Human Services.